Finally, PRL has been recognized to influence bone density [130]; in particular, postmenopausal women with hyperprolactinemia show multiple effects on bone metabolism, affecting both bone mass and density, which in turn is associated with a high risk of osteoporosis [131]. This evidence concerns the gene PRL and hyperprolactinemia.